Laurence Brunet

机构：Centre National de la Recherche Scientifique, Université Sorbonne Nouvelle, Fayetteville State University, Université Sorbonne Paris Nord, Assistance Publique – Hôpitaux de Paris, GridBridge (United States), Bicêtre Hospital, Institut des sciences juridique et philosophique de la Sorbonne, Université Paris 1 Panthéon-Sorbonne · ORCID：0000-0001-8467-4835

发表论文 166 篇 · 总被引 1360 次 · h-index 19

代表论文

• Monitoring and risk of hepatitis B reactivation and hepatitis flare during tenofovir interruption among people with HIV and hepatitis B (2025 · AIDS · 被引 9)
• Weight loss with real-world doravirine use in the OPERA cohort: a US-based cohort study (2025 · AIDS Research and Therapy · 被引 3)
• 508. Cabotegravir Long-Acting for Pre-Exposure Prophylaxis (PrEP): Real World Data on On-Time Dosing, HIV Testing and HIV Acquisition from the OPERA Cohort (2025 · Open Forum Infectious Diseases · 被引 3)
• Comparable real‐world effectiveness between switches to cabotegravir + rilpivirine long‐acting or modern daily oral regimens in the United States: an OPERA cohort study (2025 · Journal of the International AIDS Society · 被引 2)
• Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide (2025 · AIDS Research and Therapy · 被引 2)
• 390. Lenacapavir Adherence and Effectiveness Over 2 Years of Use in the OPERA Cohort (2026 · Open Forum Infectious Diseases · 被引 1)